Lv2
115 积分 2021-11-12 加入
Editorial: 10-year data on oral selexipag: Long-term survival, safety, and dosing insights in pulmonary arterial hypertension from the GRIPHON study and its open-label extension-big data-small impact
1天前
已关闭
The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
15天前
已完结
Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study
1个月前
已完结
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
